An Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD)

Overview

The purpose os this study is examine the effect and feasibility (usability and satisfaction) of an iCBT (GROw program) for adults with PGD

Full Title of Study: “An Internet-based Self Applied Treatment Program for Prolonged Grief Disorder (PGD): A Multiple-baseline Case Series Study”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Treatment
    • Masking: None (Open Label)
  • Study Primary Completion Date: May 1, 2021

Detailed Description

The death of a loved one has physical, psychological, and social consequences. Between 9.8 and 21.5% of people who lose a loved one develop Prolonged Grief Disorder (PGD). Internet- and computer-based interventions (i.e., Internet-delivered Cognitive-Behavioral Therapy, iCBT) are cost-effective and scalable alternatives that make it possible to reach more people with PGD. The main goal of the present investigation was to examine the effect and feasibility (usability and satisfaction) of an iCBT (GROw program) for adults with PGD. A secondary objective was to detect adherence to the app (Emotional Monitor) used to measure daily grief symptoms. The study had a single-case multiple-baseline AB design with six participants. The GROw program is organized sequentially in eight modules, and it is based on the dual-process model of coping with bereavement. Evaluations included a pre-to-post treatment assessment of depression, grief symptoms, and typical grief beliefs, along with daily measures of symptom frequency and intensity on the Emotional Monitor App. Treatment opinions and adherence to the App were also collected. Efficacy data were calculated using a Nonoverlap of All Pairs (NAP) analysis and Reliable Change Index (RCI).

Interventions

  • Behavioral: GROw: An Internet based Self Applied Treatment Program for Prolonged Grief Disorder (PGD)
    • It is a self-applied treatment through the web “psicologíaytecnología.labpsitec.es”. There are 8 treatment modules. Each module lasts approximately 60 minutes. It contains written information, videos, audios, photos and interactive questionnaires. The total duration of treatment is 8-10 weeks. A support call will be made a week (maximum 10 minutes) to answer questions and reinforce and motivate the patient. No additional clinical content or counselling will be provided. Main components of the treatment: Motivation for change, Psychoeducation, Behavioral activation, Exposure, Mindfulness and compassion strategies, integration of loss, restoration and reconstruction of meaning, Cognitive reappraisal and Relapse prevention

Arms, Groups and Cohorts

  • Experimental: Treatment condition – 9 days wait
    • Internet-based Self Applied Treatment Program. Main components: Motivation for change, Psychoeducation, Behavioral activation, Exposure, Mindfulness and compassion strategies, integration of loss, restoration and reconstruction of meaning, Cognitive reappraisal and Relapse prevention
  • Experimental: Treatment condition – 12 days wait
    • Internet-based Self Applied Treatment Program. Main components: Motivation for change, Psychoeducation, Behavioral activation, Exposure, Mindfulness and compassion strategies, integration of loss, restoration and reconstruction of meaning, Cognitive reappraisal and Relapse prevention
  • Experimental: Treatment condition – 17 days wait
    • Internet-based Self Applied Treatment Program. Main components: Motivation for change, Psychoeducation, Behavioral activation, Exposure, Mindfulness and compassion strategies, integration of loss, restoration and reconstruction of meaning, Cognitive reappraisal and Relapse prevention
  • Experimental: Treatment condition – 19 days wait
    • Internet-based Self Applied Treatment Program. Main components: Motivation for change, Psychoeducation, Behavioral activation, Exposure, Mindfulness and compassion strategies, integration of loss, restoration and reconstruction of meaning, Cognitive reappraisal and Relapse prevention
  • Experimental: Treatment condition – 33 days wait
    • Internet-based Self Applied Treatment Program. Main components: Motivation for change, Psychoeducation, Behavioral activation, Exposure, Mindfulness and compassion strategies, integration of loss, restoration and reconstruction of meaning, Cognitive reappraisal and Relapse prevention

Clinical Trial Outcome Measures

Primary Measures

  • Change in Emotional Pain: intensity of sadness, anger, anxiety, guilt and grief
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • * Evaluation from mobile app Item 1: In relation to the death of your loved one; What intensity of sadness have you felt TODAY? Item2: In relation to the death of your loved one; What intensity of anger have you felt TODAY? Item 3: In relation to the death of your loved one; What intensity of anxiety have you felt TODAY? Item 4: In relation to the death of your loved one; What intensity of guilt have you felt TODAY? Item 5: In relation to the death of your loved one; What intensity of pain from loss have you felt TODAY? * Evaluation from mobile app

Secondary Measures

  • Change in frequency of sad memories
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you remembered TODAY the absence of your loved one with enormous and deep sadness? * Evaluation from mobile app
  • Change in frequency of memories that produce anger
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you remembered TODAY the absence of your loved one with a huge and deep anger? * Evaluation from mobile app
  • Change in frequency of memories that produce anxiety
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you remembered TODAY the absence of your loved one with enormous and deep anxiety? * Evaluation from mobile app
  • Change in frequency of memories that produce guilt
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you remembered TODAY the absence of your loved one with a huge and deep guilt? * Evaluation from mobile app
  • Change in frequency of pleasant memories
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you had pleasant memories with your loved one TODAY? * Evaluation from mobile app
  • Change in emotion avoidance frequency
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you wished TODAY to get rid of your unpleasant emotions related to your loved one? * Evaluation from mobile app
  • Change in thoughts avoidance frequency
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you tried TODAY to get rid of unpleasant thoughts related to your loved one? * Evaluation from mobile app
  • Change in difficulty accepting the death
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you thought TODAY that you cannot believe that your beloved family has died? * Evaluation from mobile app
  • Change in difficulty accepting the death
    • Time Frame: Once a day (from the start of the baseline until the end of the treatment) and at 3 and 12 months after the end of the treatment
    • Item: How often have you wished TODAY intensely that your loved one was with you?

Participating in This Clinical Trial

Inclusion Criteria

  • Age ≥ 18 years – Meeting diagnostic criterio for PGD – Sign an informed consent – Ability to understand and read Spanish – Abilitiy to use a computer and having access to the Internet – Having an e-mail address Exclusion Criteria:

  • Presence of risk of suicide or self-destructive behaviors – Presence of another severe mental disorder (substance abuse or dependence, pshychotic disorder, dementia o bipolar disorder) – Presence of severe personality disorder – Presence of a medical condition whose severity or characteristics prevent the performance of treatment – Receiving other psychological treatment during the study for PGD – An increase and/or change in the medication during the study period

Gender Eligibility: All

Minimum Age: 18 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • Universitat Jaume I
  • Provider of Information About this Clinical Study
    • Sponsor

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.